All CF NBS strategies that are currently performed in NBS programs start with immunoreactive trypsinogen (IRT) on blood spots, usually in combination with a second IRT test (IRT2), pancreatitis-associated protein (PAP) on blood, or CFTR mutation analysis (DNA) [8]. The gene discussed is CFTR; the disease is cystic fibrosis.